Our study found that although the expression levels of AHNAK2 differ in various tumors, they are significantly positively correlated with tumor progression and short OS in pan-cancer patients, indicating that AHNAK2 also has universal prognostic value in pan-cancer. The gene discussed is AHNAK2; the disease is neoplasm.